• Endocrinology-Autoimmune Disorders Conference, all presentations

    Original Date: April 13-14, 2019

    This discounted package includes all of the individual presentations from the conference.

    12.5 CEUs (including 1.0 pharmacy, 11.5 general) approved by OBNM
  • The Many Faces of Metabolic Syndrome: Insulin resistance, PCOS, Hypo and Hyperandrogenism

    Presenter: Robyn Kutka, ND
    Original Date: April 13, 2019

    It’s estimated that 25% of the world’s adult population has metabolic syndrome. This condition imposes significant health risks including a five-fold greater risk of type 2 diabetes and triple the risk of heart attack or stroke as compared to people without metabolic syndrome. Associated cardiovascular disease accounts for much of the financial burden associated with both metabolic syndrome and overt diabetes. Given these astounding numbers and global burden on health care budgets, it’s clear that earlier diagnosis and preventative approaches are needed.

    Join us as we uncover diagnostic early indicators of metabolic syndrome and more overt disease processes including insulin resistance, diabetes and PCOS. Understand the pathophysiology and clinical presentations as the pertain to androgens and differ among the sexes. Review clinical cases from presentation through diagnosis and treatment, taking away clinical pearls ready to implement in your practice Monday Morning.

    1.5 (1.0 pharmacy, .5 general) CEUs approved by OBNM
  • The Paradox of Weight Gain- How Gaining Weight Makes Us Fat

    Presenter: Serena Goldstein, ND
    Original Date: April 13, 2019

    Our endocrine system is pretty tightly regulated, and comprised of multiple organs with multiple signals to keep everything balanced. However, fat cells are their own organ system that tends to interrupt these signals in such a way that can manifest as weight gain, as well as other hormonal based concerns that also pose an uphill battle to not only losing weight, but also maintaining weight loss goals through an optimal functioning metabolism. This presentation will discuss the different types of hormone imbalances that affect weight gain especially as we age, how to motivate the patient to create change, and various Naturopathic therapies to address the pathophysiology of weight gain and the root cause of disease.

    1.5 general CEUs approved by OBNM
  • Assessment of Steroidal Hormones and Related Naturopathic Care

    Presenter: Andrew L. Rubman, ND
    Original Date: April 13, 2019

    Clinical Issues involving steroidal hormones will be covered in three ½ hour segments:
     Methodology of measurement will be discussed detailing the strengths and weaknesses of currently used laboratory measures
     The biochemistry of the steroidal cascade of the sexual and adrenal hormones, their precursor substances, and their metabolites will be discussed. Important factors affect modulatory enzymes and the management of precursors and metabolites will be illustrated.
     Three cases involving modulation of steroidal hormones including all intake parameters, laboratory assessments, and treatment follow-up will be covered

    1.5 general CEUs approved by OBNM
  • Psychoneurointracrinology: The Mind-brain Continuum

    Presenter: Susan Gordon, PhD
    Original Date: April 13, 2019

    This presentation explores the construct psycho-neuro-intracrinology, which represents a complex system that is psychological, neurological and intracrinological and reveals a mind-brain continuum within the person. The example of women during the midlife transition provides a model of the development of personality and the ontogenesis of self with implications for women across the lifespan and to men through similar neurohormonal mechanisms. This lecture focuses on the nature of consciousness and the self and the biochemical mechanisms explaining the scientific and clinical applications of the psychoneurointracrine hypothesis. Two neurobiological theories of the mind-brain continuum are advanced: (1) the theory of psychoneurointracrine autopoiesis explains how the regulation of a steroid’s receptor is modulated by the person’s perception of experience and sense of well-being, and (2) the theory of emergent global states explains how limbic projections from the hypothalamic-pituitary-gonadal and adrenal axes regulate the reactive and anticipatory response to stress. This construct extends knowledge of the mind-brain relationship, the person-centered approach to science, and the growth-oriented dimension of personality.

    1.5 general CEUs approved by OBNM
  • Autoimmunity: Mechanism’s and Controversies

    Presenter: Heather Zwickey, PhD
    Original Date: April 14, 2019

    Why is autoimmunity is increasing in the United States and worldwide? The rate of increase suggests environmental mechanisms. While genetics clearly play a role in autoimmunity, current research suggests that infectious disease, diet, toxic chemicals, and gut dysbiosis may be more to blame. This seminar will examine the current mechanisms for autoimmune disease, environmental triggers, and controversies associated with autoimmune disease.

    1.5 general CEUs approved by OBNM
  • Clinical Utility of Continuous Glucose Monitoring in Autoimmune Diabetes

    Presenter: Patrick Chapman, ND & Julie Verfurth, ND
    Original Date: April 14, 2019

    Selected attendees and patients (both diabetic and non-diabetic) are connected to a continuous glucose monitoring system for 72 or more hours. Real-time glucose numbers will be transmitted and interesting highlights of the glucose data and dietary diaries are analyzed during the presentation. Relevant patient data from Dr. Chapman's diabetes-focused practice are also presented. Dr. Chapman also discusses the clinical utility of CGMS (continuous glucose monitoring system) in the naturopathic primary care setting in prevention and treatment of both autoimmune and type 2 diabetes mellitus. Clinical relevance will include cost, safety, CGMS initiation, dietary analysis, prevention of hypoglycemia, medication adjustments, and reduced hospital interventions. Audience participation will be implemented through questions and case studies
    The presentation on CGMS will be followed by a more general discussion on autoimmune diabetes management with Julie Verfuth, ND. Drs. Chapman and Verfurth discuss various approaches to optimal glucose management.

    1.5 general CEUs approved by OBNM
  • Autoimmune Thyroid and Pain: What’s the Connection?

    Presenter: Tyna Moore, ND, DC
    Original Date: April 14, 2019

    While autoimmune thyroid conditions are common, few doctors understand or respect the intimate relationship between this condition and chronic pain. Common conditions that are treated as purely musculoskeletal conditions often have a hormonal component and often this link ultimately finds it’s root cause in an autoimmune condition.
    Pharmaceutical interventions such as thyroid replacement hormone can often be a quick and effective treatment choice for many musculoskeletal conditions that could otherwise go on inappropriately diagnosed and treated as strictly biomechanics in nature.

    1.5 general CEUs approved by OBNM
  • Microbiome-Immune Interactions in Autoimmune Disease: Current Understanding & Therapeutic Implications

    Presenter: Tom Fabian, PhD
    Original Date: April 14, 2019

    Research into the role of the microbiome in autoimmune disease has advanced rapidly in recent years, implicating microbiome-immune system interactions as critical factors may promote the development of autoimmunity. Microbial dysbiosis may lead to decreased immune tolerance and increased inflammatory activity, both of which are thought to be essential features of many autoimmune diseases. In addition, certain normal (commensal) microbes and pathogens can promote autoimmune reactivity via specific mechanisms, such as molecular mimicry and protein modification.
    Current understanding of the role of microbiome-immune interactions will be discussed in the context of specific autoimmune diseases. Clinical applicability of the information presented will be illustrated through examples of functional testing results (including microbiome, immune and genomic tests), and microbiome-based therapeutic approaches. We will conclude with a brief discussion of the prospects for a paradigm shift in the understanding – and treatment - of autoimmune diseases.

    2.0 general CEUs approved by OBNM

Privacy Policy